Frederik Novak

3PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 14, 2026
Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.

|Apr 22, 2024
Extended interval dosing with ocrelizumab in multiple sclerosis.

Frederik Novak, Hamza Mahmood Bajwa, Kamilla Østergaard

|May 15, 2023
Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses.

Frederik Novak, Hamza Mahmood Bajwa, John Eugenio Coia

Pageof 1

Frequent Collaborators

1 joint publications

Keld-Erik Byg

1 joint publications

René Carvajal

1 joint publications

Izanne Roos

1 joint publications

Alvaro Cobo-Calvo